Lauren Sankary JD MA
Presented on Wednesday, May 15, 2019 – 4:00 PM MST
Watch this webinar: http://bit.ly/2Jod7u8
Deep brain stimulation (DBS) was approved by the FDA as a treatment for Parkinson’s Disease in 1997, and has since been approved for use in the treatment of dystonia, obssessive-compulsive disorder, and in 2018 as a treatment for epilepsy. Beyond the potential complications from surgery as the device and its electrodes are implanted, there are also potential neuropsychiatric side effects after DBS and ongoing considerations related to battery replacement or device removal. What ethical considerations arise when implanted neurotechnology alters the brain?
Lauren Sankary, JD MA is a NIH BRAIN Initiative Postdoctoral Research Fellow at the Cleveland Clinic. She leads the discussion on these dilemmas.